These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3934146)

  • 21. [Acquired hemophilia A, successfully treated with immunosuppressive therapy and plasma exchange].
    Maruyama D; Nishiwaki K; Sano K; Masuoka S; Yokoyama H; Hagino T; Katayama T; Kobayashi M
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1537-9. PubMed ID: 13677906
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful management of a patient with an acquired factor VIII inhibitor.
    Sultan Y; Maisonneuve P; Bismuth A; Steg A
    Transfusion; 1983; 23(1):62-4. PubMed ID: 6402833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit.
    Motta M; Del Vecchio A; Radicioni M
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():129-31. PubMed ID: 21942611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypercoagulemic disorders of hemostasis and disseminated intravascular coagulation syndromes (clinical, diagnostic, treatment and prophylactic problems)].
    Levitskaia SV
    Pediatriia; 1984 Jun; (6):69-73. PubMed ID: 6473003
    [No Abstract]   [Full Text] [Related]  

  • 25. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemofil and other factor VIII concentrates.
    Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
    Tanaka I; Shima N
    Rinsho Ketsueki; 2005 Feb; 46(2):91-8. PubMed ID: 16447701
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent trends in the management of hemophilia.
    Dubey SM; Agarwal KN
    Indian Pediatr; 1974 May; 11(5):359-65. PubMed ID: 4426664
    [No Abstract]   [Full Text] [Related]  

  • 29. [Physiology of hemostasis].
    Caen JP
    Hamatol Bluttransfus; 1970; 9():96-108. PubMed ID: 4927517
    [No Abstract]   [Full Text] [Related]  

  • 30. Assay of clotting factors in outdated blood bank plasma and its potenial use for therapy in hemophilia and other hemorrhagic dyscrasias.
    Rosenthal RL; Sloan E
    Transfusion; 1966; 6(4):289-92. PubMed ID: 5965694
    [No Abstract]   [Full Text] [Related]  

  • 31. The situation of the haemophiliac: yesterday and today.
    Egli H
    Haemostasis; 1981; 10 Suppl 1():1-10. PubMed ID: 6790370
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemostatic disorders in pregnancy and the peripartum period.
    Hobisch-Hagen P; Mörtl M; Schobersberger W
    Acta Anaesthesiol Scand Suppl; 1997; 111():216-7. PubMed ID: 9421019
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disorders of blood coagulation in the intensive care unit: what is important for diagnosis and therapy?].
    Seitz R; Egbring R
    Klin Wochenschr; 1991; 69 Suppl 26():143-9. PubMed ID: 1813711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgery in hemophilia A patients with factor VIII inhibitor: 10-year experience.
    Scharf R; Kucharski W; Nowak T
    World J Surg; 1996; 20(9):1171-81. PubMed ID: 8864078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis.
    Beck KH; Mortelmans Y; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1994; 32():440-4. PubMed ID: 9422123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemostasis during MARS therapy and hemodiafitration in patiens with acute renal-hepatic failure].
    Iampol'skiĭ AF; Eremeeva LF; Menshchikov VV; Zabolotskikh IB
    Anesteziol Reanimatol; 2012; (3):71-4. PubMed ID: 22993931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach.
    Scola MR; Baggesen LM; Nichols TC; Key NS; Gallippi CM
    Thromb Res; 2012 May; 129 Suppl 2(0 2):S57-61. PubMed ID: 22405050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatment of patients with inhibitors to factor VIII.
    Hilgartner MW
    Haematologia (Budap); 1986; 19(1):21-32. PubMed ID: 3087840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of life-threatening bleeding by combined plasmapheresis and immunosuppressive treatment in a haemophiliac with inhibitors.
    Révész T; Mátyus J; Goldschmidt B; Harsanyi V
    Arch Dis Child; 1980 Aug; 55(8):641-3. PubMed ID: 6776907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation.
    Azad SC; Kratzer MA; Groh J; Welte M; Haller M; Pratschke E
    Semin Thromb Hemost; 1993; 19(3):233-7. PubMed ID: 8362253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.